Picard Medical, Inc. (PMI)

Market Cap	16.91M -95.2%
Revenue (ttm)	6.30M +41.2%
Net Income	-26.42M
EPS	-17.88
Shares Out	2.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,266
Open	6.86
Previous Close	6.83
Day's Range	6.84 - 7.30
52-Week Range	2.65 - 224.59
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About PMI

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 29, 2025
• Employees: 75
• Stock Exchange: NYSE American
• Ticker Symbol: PMI
• Website: https://www.picardmedical.com

Financial Performance

In 2025, Picard Medical's revenue was $4.94 million, an increase of 12.50% compared to the previous year's $4.39 million. Losses were -$27.00 million, 13.8% more than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 29, 2026

Data Sources Report a data error